Employing bioinformatic tools, including GO, KEGG, GSVA, and GSEA, we elucidated RNF149’s prospective roles in facilitating cancerous growth, impeding immune response, modulating cellular signaling, and fostering drug resistance in AML. The gene discussed is RNF149; the disease is acute myeloid leukemia.